Clinical Trial Update: A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes. [Phase 2]

View source ↗

Summary

Completed Phase 2 trial comparing aleglitazar to pioglitazone (Actos) on renal function in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Aleglitazar (Aleglitazar)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED